Liberty Health Sciences Announces CBD Product Line Derived from Industrial Hemp

Liberty Health Sciences to Launch Zentient Labs CBD Portfolio of Products

Liberty offers range of premium, natural hemp-based products of ultra-high-quality CBD, nutraceuticals and vitamins designed to enhance health and wellness

TORONTO, Dec. 20, 2018 /CNW/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) (“Liberty” or the “Company”), a provider of high quality cannabis, today announced the launch of Zentient Labs, a line of premium hemp-based CBD products made from a proprietary formula of ultra-high quality CBD, nutraceuticals and vitamins that promote energy and focus for wellness seekers.

The CBD market is experiencing dramatic growth and is predicted to grow to $2.1 billion in consumer sales by 2020, with $450 million of those sales coming from hemp-based sources. Demand for CBD has also increased rapidly due in large part to the wide variety of ways it can be used in products, ranging from food and cosmetics to beverages and a myriad of health supplements.

Liberty Health Sciences is quickly becoming a leading cultivator and distributor of premium cannabis products through low-cost production techniques and high-end dispensary design and intends to apply the same techniques to the cultivation and distribution of hemp-derived products. We currently operate two facilities in Florida with a total cultivation capacity of over 41,000 square feet.

George Scorsis, CEO of Liberty Health Sciences

The Company has increased its cultivation capacity to more than 120,000 square feet and will grow to approximately 225,000 square feet by early 2019. Our processing facility utilizes state-of-the-art equipment and techniques for extraction and purification and our experience with medical marijuana is directly applicable to industrial hemp.

Zentient Labs will include a line of products across numerous categories including propriety brands and partner brands. These categories will include an athletic line, a wellness line, beauty and premium pet products.

Liberty carefully selected the brand name Zentient Labs to deliver on a promise to provide high-quality CBD products to customers who seek out creative pursuits, the deepest of relaxation and the most aggressive sports activities. The Company did extensive consumer research to define what this brand will represent.

Zentient Labs’ line of wellness products was designed to support your desired activity, so you can be in the ‘Zentient Zen state’, as we call it. When ‘in the zone’, you become one with the activity, lost in the rhythm of the tasks at hand. It’s characterized by complete connectedness and presence, being solely focused on that exact moment in time. This is what our exciting line of products looks to support. Let’s face it, with the pace of life these days, many of us strive to be more conscious and in the now.

Stephanie Kubacki, Vice President of Marketing, Liberty Health Sciences

Liberty used the services of Theory SF, a multi-disciplinary marketing agency located in the heart of San Francisco to create the Zentient Labs brand image.

About Liberty Health Sciences Inc.

Liberty is the cannabis provider committed to providing a trusted, high quality cannabis experience based on our genuine care for all cannabis users and a focus on operational excellence from seed to sale and beyond. Liberty’s measured approach to expansion opportunities maximizes returns to shareholders, while keeping consumers’ well-being at the forefront of what we do. For more information, please visit:

Original press release

Get ahead of the crowd by signing up for 420 Investor when it becomes available again. It’s the largest & most comprehensive premium service for cannabis investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter